Announcements Trials

Browse Landscape

Phase

Phase NA 3 Phase 3 1 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Weight Loss 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Motor Activity 1 Lung Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Intraductal, Noninfiltrating 1 Cachexia 1 Breast Neoplasms 1 Body Weight 1

Interventions

Carboplatin 195 Cisplatin 117 Paclitaxel 107 Pemetrexed 106 Docetaxel 96 Gemcitabine 89 Radiotherapy 83 Erlotinib Hydrochloride 58 Bevacizumab 55 Etoposide 49 durvalumab 39 pembrolizumab 38 Nivolumab 31 Specimen Handling 30 Magnetic Resonance Spectroscopy 30 Irinotecan 27 Radiosurgery 26 osimertinib 24 Gefitinib 24 Drug Therapy 23 Vinorelbine 22 atezolizumab 20 Topotecan 20 Radiation 16 Cetuximab 16 Taxes 15 Surgical Procedures, Operative 14 Neoadjuvant Therapy 13 Filgrastim 13 Chemotherapy, Adjuvant 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lung Neoplasms × Nutrition Assessment × Clear all

NCT02019979 2018-05-04

METRO

Beth Israel Medical Center

Phase 2 Terminated

14 enrolled 7 charts

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡